What results can you expect from retatrutide? Week-by-week breakdown of typical outcomes, Phase 2 trial data and realistic expectations for UK buyers.
Everything you need to know about retatrutide side effects before starting — from Phase 2 clinical trial data. What’s common, what’s rare, what to do and when to seek help.
Complete retatrutide dosage guide 2025 — starting dose, titration schedule, pen click calculator and what to expect at each stage. Based on NEJM Phase 2 clinical trial data.
Retatrutide is a next-generation triple agonist peptide that simultaneously activates GLP-1, GIP and GCG receptors — producing up to 24% body weight reduction in Phase 2 trials. Here’s exactly how it works.